Showing 861-870 of 5804 results for "".
DermWireTV: Dermatology Moves Beyond the COVID-19 Crisis
https://practicaldermatology.com/topics/practice-management/dermwiretv-dermatology-moves-beyond-the-covid-19-crisis/19815/This special edition of DermWireTV takes a look at the dermatology space as offices reopen. Includes updates on disease spread from WHO, advice on PCR and antibody testing, as well as tips for reopening from Suneel Chilukuri, MD (Refresh Dermatology) and Kimberly Campbell. Plus, Amy Forman Taub, MDCaring for Acne and Rosacea Patients in the COVID-19 Era
https://practicaldermatology.com/topics/acne-rosacea/caring-for-acne-and-rosacea-patients-in-the-covid-19-era/23280/Telederm may not be ideal, but it is essential for acne and rosacea patients today—and could persist in the future.Novel Treatments for Acne
https://practicaldermatology.com/topics/acne-rosacea/novel-treatments-for-acne/19761/Joshua Zeichner, MD discusses three new treatments now available in the acne treatment armamentarium. For patients with severe acne, a new low-dose isotretinoin in a micronized formulation allows for better absorption, even without food. Dr. Zeichner also discusses the benefits of a new topical retiSpecial Report: COVID-19 Impact and Response
https://practicaldermatology.com/topics/practice-management/special-report-covid-19-impact-and-response/19752/The COVID-19 pandemic is causing a halt in elective surgeries and forcing dermatology and aesthetics practices to temporarily close. Hear from those affected. Telemedicine is expanding in response to patient needs, as OCR addresses HIPAA enforcement. Learn about enforcement and new technology optionThe Pitfalls of Excessive Electronic Communication: “I Didn’t See That Email”
https://practicaldermatology.com/topics/practice-management/the-pitfalls-of-excessive-electronic-communication-i-didnt-see-that-email/23132/All communication should be thoughtful and intentional. Where does technology fit in?Atopic Dermatitis: Rethinking the “Typical” Patient
https://practicaldermatology.com/topics/atopic-dermatitis/atopic-dermatitis-rethinking-the-typical-patient/19666/It's possible to make generalities about the experience of atopic dermatitis, but it's increasingly clear that there is no "typical" patient. Zelma Chiesa Fuxench, MD discusses the latest findings on the signs and symptoms of AD and the populations affected.What ’s the Best Approach to AK Therapies? Ask an Expert
https://practicaldermatology.com/topics/skin-cancer-photoprotection/what-s-the-best-approach-to-ak-therapies-ask-an-expert/19622/Rather than consider AK a specific disease, Vishal A. Patel, MD, FAAD says it can be viewed as a marker of disease, which culminates in SCC. In this edition of Ask an Expert with Adam Friedman, MD, about his philosophy of treatment, including long-term maintenance.Utilizing Digital Marketing for the Success of Your Dermatology Practice
https://practicaldermatology.com/topics/practice-management/marketingsuccess/19533/Marketing your dermatology services digitally is sine-qua-non in today's world. If you are not already doing so, you need to start as soon as possible. This Ekwa Marketing video explains five ingredients which are essential for a successful digital marketing strategy.Skin Cancer Awareness, Epiduo Data, Impoyz Launch
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-skin-cancer-awareness-epiduo-data-impoyz-launch/18307/Data shed light on patents' attitudes towards kids' sunblock and new findings emerge on melanoma risks. FDA accepts BLA for cemiplimab for advanced SCC and approves Novartis' Tafinlar in combination with Mekinist for the adjuvant treatment of patients with melanoma with BRAF V600E or V600K mutationsWhat's Next in Aesthetic Medicine?
https://practicaldermatology.com/topics/practice-management/whats-next-in-aesthetic-medicine/20523/Insights on the future of cosmetic care from DermTube.com.